Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study
- PMID: 26599351
- DOI: 10.1002/hep.28368 (VSports手机版)
"VSports手机版" Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study
Abstract
Nonalcoholic fatty liver disease (NAFLD) represents the hepatic manifestation of metabolic syndrome and may evolve into hepatocellular carcinoma (HCC). Only scanty clinical information is available on HCC in NAFLD. The aim of this multicenter observational prospective study was to assess the clinical features of patients with NAFLD-related HCC (NAFLD-HCC) and to compare them to those of hepatitis C virus (HCV)-related HCC. A total of 756 patients with either NAFLD (145) or HCV-related chronic liver disease (611) were enrolled in secondary care Italian centers. Survival was modeled according to clinical parameters, lead-time bias, and propensity analysis. Compared to HCV, HCC in NAFLD patients had a larger volume, showed more often an infiltrative pattern, and was detected outside specific surveillance. Cirrhosis was present in only about 50% of NAFLD-HCC patients, in contrast to the near totality of HCV-HCC. Regardless of tumor stage, survival was significantly shorter (P = 0. 017) in patients with NAFLD-HCC, 25. 5 months (95% confidence interval 21 VSports手机版. 9-29. 1), than in those with HCV-HCC, 33. 7 months (95% confidence interval 31. 9-35. 4). To eliminate possible confounders, a propensity score analysis was performed, which showed no more significant difference between the two groups. Additionally, analysis of patients within Milan criteria submitted to curative treatments did not show any difference in survival between NAFLD-HCC and HCV-HCC (respectively, 38. 6 versus 41. 0 months, P = nonsignificant) .
Conclusions: NAFLD-HCC is more often detected at a later tumor stage and could arise also in the absence of cirrhosis, but after patient matching, it has a similar survival rate compared to HCV infection; a future challenge will be to identify patients with NAFLD who require more stringent surveillance in order to offer the most timely and effective treatment V体育安卓版. .
© 2015 by the American Association for the Study of Liver Diseases V体育ios版. .
"VSports注册入口" Comment in
-
Clinical patterns of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD): a multicenter prospective study.Hepatobiliary Surg Nutr. 2017 Oct;6(5):350-352. doi: 10.21037/hbsn.2017.06.06. Hepatobiliary Surg Nutr. 2017. PMID: 29152487 Free PMC article. No abstract available.
-
NAFLD-which patients should have hepatocellular carcinoma surveillance?Hepatobiliary Surg Nutr. 2017 Oct;6(5):353-355. doi: 10.21037/hbsn.2017.06.04. Hepatobiliary Surg Nutr. 2017. PMID: 29152488 Free PMC article. No abstract available.
-
Nonalcoholic fatty liver disease and hepatocellular carcinoma: new insights on presentation and natural history.Hepatobiliary Surg Nutr. 2017 Dec;6(6):401-403. doi: 10.21037/hbsn.2017.07.07. Hepatobiliary Surg Nutr. 2017. PMID: 29312975 Free PMC article. No abstract available.
-
Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, metabolic syndrome and hepatocellular carcinoma-a composite scenario.Hepatobiliary Surg Nutr. 2018 Apr;7(2):130-133. doi: 10.21037/hbsn.2018.01.01. Hepatobiliary Surg Nutr. 2018. PMID: 29744343 Free PMC article. No abstract available.
-
Recurrence of hepatocellular carcinoma in noncirrhotic patients with nonalcoholic fatty liver disease versus hepatitis B infection.Eur J Gastroenterol Hepatol. 2023 Apr 1;35(4):431-439. doi: 10.1097/MEG.0000000000002504. Epub 2022 Dec 23. Eur J Gastroenterol Hepatol. 2023. PMID: 36728881
Publication types (VSports最新版本)
- Actions (V体育平台登录)
MeSH terms (V体育官网)
- "VSports在线直播" Actions
- Actions (VSports最新版本)
- "V体育ios版" Actions
- Actions (V体育2025版)
- "V体育平台登录" Actions
- Actions (V体育ios版)
- V体育平台登录 - Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources (VSports手机版)
Medical